Troutman Pepper advised Innervace on the deal.Innervace, a regenerative medicine company developing the first implantable biofabricated neural pathway to restore brain circuitry, announced its $40 million…
Innervace’s $40 Million Series A Financing
Troutman Pepper advised Innervace on the deal.Innervace, a regenerative medicine company developing the first implantable biofabricated neural pathway to restore brain circuitry, announced its $40 million…